# US 2023/0312767 A1 · Synergistic antifoulant compositions and methods of using the same

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0312767 A1
- Document ID: US20230312767A1
- Status: Published application
- Kind: A1
- Application number: 18/191,189
- Filed: 2023-03-28
- Published: 2023-10-05
- Earliest claimed: 2022-04-01
- Assignees: Ecolab USA Inc.
- Applicants: Ecolab USA Inc.
- Inventors: Zhenxing XI; Jonathan MASERE; Ramon COLORADO, JR.
- Web page: https://patentgrep.com/patent/US20230312767A1

## CPC

- C07C 51/64: Separation; Purification; Stabilisation; Use of additives
- C08F 2/005: {by addition of a scale inhibitor to the polymerisation medium}
- C07C 67/62: Use of additives, e.g. for stabilisation
- C07D 211/94: Oxygen atom, e.g. piperidine N-oxide
- C07D 295/24: Oxygen atoms
- C08F 18/08: Vinyl acetate
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C08F: MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

Polymerization inhibitor compositions are provided. The polymerization inhibitor compositions include at least a first inhibitor compound having a stable nitroxide radical and a second inhibitor compound having a hydroxylamine. Methods of inhibiting the polymerization of monomers using the compositions of the disclosure are also provided. The methods of inhibiting polymerization of monomers include a step of adding a composition of the disclosure to the monomer. In some instances, the monomer is an ethylenically unsaturated monomer. Such ethylenically unsaturated monomers include, but are not limited to, vinyl acetate, acrylonitrile, acrylates, methacrylates, 1,3-butadiene, styrene, isoprene, (meth)acrylic acid, and combinations thereof. Methods of preparing the polymerization inhibitors and compositions of the disclosure are also provided.

## Claims

### Claim 1

A composition for inhibiting monomer polymerization comprising:
a first inhibitor compound comprising a stable nitroxide radical; and
a second inhibitor compound comprising a hydroxylamine.

### Claim 2 (depends on 1)

The composition of claim 1, wherein the first inhibitor compound is of formula (I):
wherein R1 is selected from H, C1-C22 alkyl, C1-C22 alkenyl, C1-C22 alkynyl, C1-C22 cycloalkyl, aryl, —C1-C22 alkylene aryl, —C(O)(C1-C22 alkyl), —C(O)(C1-C22 alkenyl), —C(O)(C1-C22 alkynyl), —C(O)(C1-C22 cycloalkyl), —C(O)(aryl), and —C(O)(C1-C22 alkylene aryl), wherein the cycloalkyl and aryl are optionally substituted with one or more C1-C22 alkyl, C1-C22 alkenyl, C1-C22 alkynyl, or aryl.

### Claim 3 (depends on 1)

The composition of claim 1, wherein R1 is selected from —C(O)(C1-C22 alkyl), —C(O)(C1-C22 alkenyl), —C(O)(C1-C22 alkynyl), —C(O)(C1-C22 cycloalkyl), —C(O)(aryl), and —C(O)(C1-C22 alkylene aryl), wherein the cycloalkyl and aryl are optionally substituted with one or more C1-C22 alkyl, C1-C22 alkenyl, C1-C22 alkynyl, or aryl.

### Claim 4 (depends on 1)

The composition of claim 1, wherein the second inhibitor compound is of formula (II):
wherein R2 is selected from H, C1-C22 alkyl, C1-C22 alkenyl, C1-C22 alkynyl, C1-C22 cycloalkyl, aryl, —C1-C22 alkylene aryl, —C(O)(C1-C22 alkyl), —C(O)(C1-C22 alkenyl), —C(O)(C1-C22 alkynyl), —C(O)(C1-C22 cycloalkyl), —C(O)(aryl), and —C(O)(C1-C22 alkylene aryl), wherein the cycloalkyl and aryl are optionally substituted with one or more C1-C22 alkyl, C1-C22 alkenyl, C1-C22 alkynyl, or aryl.

### Claim 5 (depends on 4)

The composition of claim 4, wherein R2 is selected from —C(O)(C1-C22 alkyl), —C(O)(C1-C22 alkenyl), —C(O)(C1-C22 alkynyl), —C(O)(C1-C22 cycloalkyl), —C(O)(aryl), and —C(O)(C1-C22 alkylene aryl), wherein the cycloalkyl and aryl are optionally substituted with one or more C1-C22 alkyl, C1-C22 alkenyl, C1-C22 alkynyl, or aryl.

### Claim 6 (depends on 1)

The composition of claim 1, wherein the first inhibitor compound is selected from the group consisting of:

### Claim 7 (depends on 1)

The composition of claim 1, wherein the second inhibitor compound is selected from the group consisting of:

### Claim 8 (depends on 1)

The composition of claim 1, wherein the first inhibitor compound is present in the composition at a concentration of about 0.01% by weight to about 80% by weight.

### Claim 9 (depends on 1)

The composition of claim 1, wherein the second inhibitor compound is present in the composition at a concentration of about 0.01% by weight to about 50% by weight.

### Claim 10 (depends on 1)

The composition of claim 1, wherein a mole ratio of the first inhibitor compound to the second inhibitor compound is about 100:1 to about 1:100.

### Claim 11 (depends on 1)

The composition of claim 1, wherein the composition further comprises one or more additional compounds selected from the group consisting of: 2,2,6,6-tetramethylpiperidin-1-oxyl; 2,2,6,6-tetramethylpiperidin-1-ol; 4-hydroxyl-2,2,6,6-tetramethylpiperidin-1-oxyl; 4-hydroxy-2,2,6,6-tetramethylpiperidin-1-ol; 4-oxo-2,2,6,6-tetramethylpiperidin-1-oxyl; 4-oxo-2,2,6,6-tetramethylpiperidin-1-ol; 4-acetoxy-2,2,6,6-tetramethylpiperidin-1-oxyl; 4-acetoxy-2,2,6,6-tetramethylpiperidin-1-ol; 4-propionoxy-2,2,6,6-tetramethylpiperidin-1-oxyl; 4-propionoxy-2,2,6,6-tetramethylpiperidin-1-ol; and bis((2,2,6,6-tetramethylpiperidin-1-oxyl)-4-yl) oxalate.

### Claim 12 (depends on 1)

The composition of claim 1, further comprising an ethylenic unsaturated monomer.

### Claim 13 (depends on 1)

The composition of claim 1, wherein the composition further comprises an acid or an acetaldehyde.

### Claim 14 (depends on 1)

A method of inhibiting polymerization of a monomer, the method comprising:
adding the composition of claim 1 to the monomer.

### Claim 15 (depends on 14)

The method of claim 14, wherein the monomer is provided within a solution, optionally wherein the solution further comprises one or more additional components selected from the group consisting of an acid, an organic solvent, water, and any combination thereof.

### Claim 16 (depends on 14)

The method of claim 14, wherein the composition is added to the monomer such that a concentration of the first inhibitor compound is about 0.1 ppm to about 10,000 ppm and/or a concentration of the second inhibitor compound is about 0.1 ppm to about 10,000 ppm.

### Claim 17

A process for preparing a compound of formula (III):
wherein:
R3 is —O or —OH; and
R4 is C1-C22 alkyl, C1-C22 alkenyl, C1-C22 alkynyl, C1-C22 cycloalkyl, aryl, and C1-C22 alkylene aryl, wherein the cycloalkyl and aryl are optionally substituted with one or more C1-C22 alkyl, C1-C22 alkenyl, C1-C22 alkynyl, or aryl, comprising:
treating a compound of formula (IIIa):
with a compound of formula (IIIb):
wherein R5 is C1-C22 alkyl or C1-C22 alkenyl,
within a solution, to afford the compound of formula (III).

### Claim 18 (depends on 17)

The process of claim 17, wherein the compound of formula (IIIa) is treated with the compound of formula (IIIb) in the presence of a catalyst and heat.

### Claim 19 (depends on 17)

The process of claim 17, further comprising purging the solution with a stream of nitrogen.

### Claim 20 (depends on 17)

The process of claim 17, wherein the step of purging the solution with a stream of nitrogen is performed concurrently with the step of treating a compound of formula (IIIa) with a compound of formula (IIIb) to afford the compound of formula (III), or wherein the step of purging the solution with a stream of nitrogen is performed after the step of treating a compound of formula (IIIa) with a compound of formula (IIIb) to afford the compound of formula (III).
